222
Participants
Start Date
July 6, 2011
Primary Completion Date
June 30, 2013
Study Completion Date
January 28, 2021
YKP3089
Capsule, dose to be titrated Tablet, dose to be titrated
Placebo
Placebo capsule Placebo tablet
University of Pennsylvania Health System, Philadelphia
Thomas Jefferson University Comprehensive Epilepsy Center, Philadelphia
Mid-Atlantic Epilepsy and Sleep Center, Bethesda
John's Hopkins University School of Medicine, Baltimore
University of Virginia, Charlottesville
Bradenton Research Center, Inc., Bradenton
Bluegrass Epilepsy Research, LLC, Lexington
Ohio State University Medical Center, Columbus
The University of Toledo, Toledo
Suite 209 South, Chesterfield
Clinical Trials, Inc., Little Rock
Lynn Health Science Institute, Oklahoma City
Neurological Clinic of Texas, P.A., Dallas
St. Joseph Hospital & Medical Center/Barrow Neurology Clinic, Phoenix
VA Greater Los Angeles Healthcare System, Los Angeles
Kaiser Permanente, Anaheim
Deenanath Mangeshkar Hospital & Research Centre, Pune
Bangalore Clinisearch, Bangalore
St. Theresa's General Hospital, Hyderabad
M.S. Ramaiah Medical College and Hospital, Bangalore
Mallikatta Neuro Centre, Mangalore
Max Super Specialty Hospital, Saket
Nightingale Hospital, Kolkata
NZOZ Vito-Med Sp. Zo.o, Gliwice
NZOZ Diagnomed, Katowice
SPSK Nr 7 SUM w Katowicach, Gornoslaskie CM im. Prof. Leszka Gieca, Katowice
Malopolskie Centrum Medyczne, Krakow
Centrum Leczenia Padaczki i Migreny, Krakow
Centrum Terapii Wspolczesnej, Lodz
Solumed s.c., Poznan
Dong-A University Medical Center, Busan
Keimyung University Dongsan Hospital, Daegu
Chungnam National University Hospital, Daejeon
Hallym University Sacred Heart Hospital, Gyeonggi-do
Seoul National University Hospital, Seoul
Samsung Medical Center, Seoul
Korea University Anam Hospital, Seoul
Asan Medical Center, Seoul
SK Life Science, Inc.
INDUSTRY